Pseudo Exfoliation Syndrome Clinical Trial
— PXFOfficial title:
The Natural History of Artificial Intraocular Lenses (IOL) in Eyes With Exfoliation Syndrome
Verified date | November 2012 |
Source | Aurolab |
Contact | n/a |
Is FDA regulated | No |
Health authority | India: Institutional Review Board |
Study type | Observational |
- The purpose of this study is to determine the natural course of IOL in PXF,
- To demonstrate use of a clinical grading system for PXF,
- To strategize a way to prevent IOL dislocation, subluxation post operatively,
- To demonstrate intraoperative and long-term post-operative complications associated
with phaco and PXF
- To suggest evidence-based ways to minimize these complications, by using capsular
tension rings (CTR), specific IOL material or size
Status | Active, not recruiting |
Enrollment | 1500 |
Est. completion date | May 2022 |
Est. primary completion date | December 2021 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age 40-75 - PXF with or without secondary open-angle glaucoma who present with cataract and willing to undergo phacoemulsification with IOL - Nuclear sclerosis with LOCS III grade and above - Pupil size more than 4mm on dilatation - Endothelial cell count >1,500 - No visible phacodonesis Exclusion Criteria: - Uncontrolled IOP/glaucoma - History of narrow angles, chronic narrow angle glaucoma - Any pre-existing clinical zonular dialysis or phacodonesis - Pseudo uveitis - One eyed patients - Cardiac pathology - Uncontrolled diabetes, hypertension & severe asthma - Obviously debilitated patients - Traumatic cataract - Complicated cataract - Congenital cataract - Drug induced cataract - Shallow anterior Chamber - Amblyopia - Dense posterior polar cataract - Corneal pathology - Retinal pathology - RAPD - Severe visual field defect (MD->12.0dB) - Diabetic retinopathy - Combined Surgery |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
India | Aravind Eye Hospital | Coimbatore | Tamil Nadu |
India | Aravind Eye Hospital | Madurai | Tamil Nadu |
India | Aravind Eye Hospital | Pondicherry | Tamil Nadu |
India | Aravind Eye Hospital | Tirunelveli | Tamil Nadu |
Lead Sponsor | Collaborator |
---|---|
Aurolab |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | IOL Centration / IOL Stability | 10th Year | No | |
Secondary | Visual Acuity | 10th Year | No | |
Secondary | Anterior capsular fibrosis/phimosis | 10th Year | No | |
Secondary | New onset of phacodonesis | 10th Year | Yes | |
Secondary | Development or worsening of glaucoma | 10th Year | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03310788 -
Monitoring of the IOP After SLT Using iCare Home
|
||
Recruiting |
NCT06154330 -
Safety and Efficacy of Suprachoroidal Tube Shunt in Patients With Primary Open and Pseudoexfoliation Glaucomas
|
||
Terminated |
NCT03445806 -
IOP Monitoring After Trabeculectomy Using iCare Home
|
||
Completed |
NCT04911387 -
iCare® Home vs Goldmann Applanation Tonometry
|